Dr. Clara Hwang, MD

Dr. Hwang practices at Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health.

Dr. Hwang's NPI, 1407978505, was assigned on April 6, 2007. Dr. Hwang graduated from University Of Michigan Medical School in 2001. Dr. Hwang holds Michigan license 4301077986.

Dr. Hwang's primary practice is Henry Ford Hospital, at 2799 W Grand Blvd, Detroit, MI 48202 in Wayne County. The practice phone is (313) 916-2600.

Dr. Hwang's primary practice is Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health. Dr. Hwang is also affiliated with Henry Ford Macomb Hospital. The medical group on file is Henry Ford Health. Dmand AI also links Dr. Hwang to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hwang practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Hwang's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Hwang is board certified in internal medicine by the American Board of Internal Medicine. Dr. Hwang is licensed in Michigan.

Dmand AI lists breast cancer, colorectal cancer, lung cancer and prostate cancer among the conditions Dr. Hwang treats.

CMS data shows 379 Medicare services from Dr. Hwang across 5 procedure codes in 2024, for 136 Medicare patients. Medicare paid $24,214 for them.

CMS counts 136 Medicare patients who saw Dr. Hwang in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have cancer, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hwang's median patient age at 74, with 20% women.

In 2024, Dr. Hwang wrote 1,353 Medicare Part D claims for 223 patients. 65% of them were for generic drugs. CMS names the drug for 1,176 of them, across 24 drugs with 11 or more claims each, at $4,760,883 in total drug cost. In 2023, CMS named 1,490 claims across 25 drugs.

Dr. Hwang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hwang as offering telehealth.

Dmand AI links 82 papers to Dr. Hwang, published from 2006 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Prostatic Neoplasms, COVID-19 and Double-Blind Method. Dr. Hwang has published most often in PLoS One. Dr. Hwang's most frequent co-authors are Jeremy L. Warner, MD, Mehmet Asim Bilen, MD and Rana Ramzi McKay, MD.

Dmand AI links Dr. Hwang to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Prostatic Neoplasms and Prostatic Diseases.

CMS Open Payments shows 58 general payments to Dr. Hwang from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 61% of the total. EMD Serono, Inc. paid the most, $3,951.

Dmand AI lists 1 award for Dr. Hwang, most recently CMS Stage 1 EHR in 2013.

Dr. Hwang graduated from University Of Michigan Medical School in 2001. Dr. Hwang is a member of ASCO.

Dr. Hwang is in network with 14 carriers, including Aetna, Health Alliance Plan and Priority Health. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.